The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type
Histopathology · 2024-12 · 85 (6) · 846-852
DOI: 10.1111/his.15270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 24.06.2024. Verfasst von Edward W Odell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Oral and Craniofacial Science, King's College London, London, UK. Hauptthemen laut MEDLINE: Ameloblastoma, World Health Organization, Terminology as Topic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG/Brazil), Brazilian Ministry of Health, Ministério da Saúde.
Abstract (Originalsprache)
Adenoid ameloblastoma (AA) was recently recognised as a separate tumour type in the most recent World Health Organisation (WHO) classification of head and neck tumours. This decision has been considered controversial by several groups, who have described AA as a subtype of ameloblastoma, a hybrid odontogenic tumour or to fall within the spectrum of other recognised odontogenic tumours, including dentinogenic ghost cell tumour and adenomatoid odontogenic tumour. Here we review the reasons for the WHO decision to classify AA as a separate tumour type. We also critique molecular and histological findings from recent reports published since the WHO classification. While acknowledging that the classification of tumours is constantly evolving, the balance of current evidence suggests that AA should remain a distinct tumour type, and not a subtype of ameloblastoma, pending further molecular characterisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Dentistry, Oral and Craniofacial Science, King's College London, London, UK.
- Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Division of Clinical Oral Health Sciences, International Medical University, Kuala Lumpur, Malaysia.
ORCID-Profile: Edward W Odell, Carolina Cavalieri Gomes, Selvam Thavaraj
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG/Brazil)
- Brazilian Ministry of Health
- Ministério da Saúde
Zitieren
APA
Odell, E. W., Gomes, C. C., & Thavaraj, S. (2024). The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type. Histopathology, 85(6), 846-852. https://doi.org/10.1111/his.15270
Vancouver
Odell EW, Gomes CC, Thavaraj S. The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type. Histopathology. 2024;85(6):846-852. doi:10.1111/his.15270
BibTeX
@article{Odell2024,
author = {Odell, Edward W and Gomes, Carolina Cavalieri and Thavaraj, Selvam},
title = {The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type},
journal = {Histopathology},
year = {2024},
volume = {85},
number = {6},
pages = {846--852},
doi = {10.1111/his.15270}
}
EUVIMED